PepCon-2008 Shenzhen, China on April 22-24, 2008
Advances in peptide and protein researches are occurring at an ever increasing pace, in a wide range of fields and scientific disciplines. At this exciting time, it is especially important to promote scientific and technological exchange and cooperation at the international level.
To establish of a new educational and networking platform for protein and peptide sciences for international academic and industrial institutions and professionals in the area, PepCon Committee has assembled an exciting scientific program, PepCon-2008, of local and international invited speakers, covering the areas of cutting edge peptide and protein researches. More than 500 participants are expected, including 300 scientists from academic, industrial and government research institutions, 100 best local and international academic and medical research institutions as well as 80 world-famous bio-pharmaceutical and instrumentation industries. The conference will be held in Shenzhen, China on April 22-24, 2008 and will take the form of lectures, workshops, round table conferences and posters around the theme of Peptide & Protein Technology: From Concept to Market .
Featuring Six Tracks:
—- Great Minds and Innovations —-
Track I: Human Proteome Technologies- Deciphering Genome with powerful tools of Proteomics
Session 1: Frontier of Emerging Human Proteome Technologies
Session 2: Breakthrough in Major Disease Proteomics and System Biology
Session 3: Bioinformatics and Structural Proteomics
Session 4: Industry-Sponsored Symposia on Proteomics
Session 5: Protein/Peptide Structure Activity and Interaction
Track II: Protein/Peptide Biomarker Discoveries- Essential Pathway to Seek Specific Solutions
Session 6: Biomarkers in Early Drug Development
Session 7: Biomarkers in Clinical Development
Session 8: Biomarkers for Molecular Diagnostics
Session 9: Biomarker Testing and Analysis Technologies Development
Track III: Protein /Peptide Drug Discovery - Build up New Product Pipeline for Severe Diseases
Session 10: From CADD to Booming Peptide Drug Development
Session 11: Peptide / Protein as Anti-Cancer Agents
Session 12: Peptide / Protein as Anti-Infective Drugs
Session 13: Proteins/Peptides for CNS Diseases
Session 14: Proteins/Peptides For Cardiovascular & Cerebrovascular Disease
Session 15: Peptide / Protein Drug Delivery Technology
—- Demand on Improving Productivities —-
Track IV: Solutions to Antibodies/Vaccines- Off-shore Operation Opportunities
Session 16: Protein and Peptide Vaccine Research and Development
Session 17: Outsourcing Antibody Development and Production
Session 18: Investment and Business Trends Driving Biotechnology
Track V: Bioprocesses for Industrial Proteins- Riding on the Third Wave
Session 19: Rising Industrial Biotechnology for Large Scale Manufacturing & Contract Outsourcing
Session 20: New Expression Systems: Cell Line & Cell Culture Engineering
Session 21: Accelerating Production of Commercialized Proteins and Enzymes
Part VI: Renaissance of Peptide Market-Cost-Effective for Success
Session 22: Increasing Efficiency of Peptide Synthesis and Manufacturing
Session 23: off-Shore Customized Preparation/Production for Cost-Effective Therapeutics Development
Session 24: Technology Transfer for Protein/Peptide
